Literature DB >> 8641762

The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.

F C Gibson1, A O Tzianabos, A B Onderdonk.   

Abstract

To stimulate early-phase immunologic events following Bacteroides fragilis infection in the peritoneal cavity, we examined the cytokine response of several cell types to purified capsular polysaccharide complex (CPC) and lipopolysaccharide (LPS) of this organism. Cytokines were produced from murine resident peritoneal (MRP) cells as well as human peripheral blood leukocytes. MRP cells cocultured with either B. fragilis CPC of LPS in vitro produced tumor necrosis factor alpha and interleukin-1alpha (IL-1alpha). In addition, MRP cells challenged with CPC produced IL-10. Human peripheral blood monocytes and polymorphonuclear leukocytes secreted IL-8 when cultured in the presence of CPC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641762      PMCID: PMC173883          DOI: 10.1128/iai.64.3.1065-1069.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.

Authors:  A B Onderdonk; D L Kasper; R L Cisneros; J G Bartlett
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis.

Authors:  A A Lindberg; A Weintraub; U Zähringer; E T Rietschel
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

4.  Bacteroides fragilis subspecies in clinical isolates.

Authors:  B F Polk; D L Kasper
Journal:  Ann Intern Med       Date:  1977-05       Impact factor: 25.391

5.  Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber.

Authors:  A B Onderdonk; R L Cisneros; J H Crabb; R W Finberg; D L Kasper
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis.

Authors:  M E Shapiro; D L Kasper; D F Zaleznik; S Spriggs; A B Onderdonk; R W Finberg
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

Review 7.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

8.  Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage.

Authors:  R Moser; B Schleiffenbaum; P Groscurth; J Fehr
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

9.  Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures.

Authors:  J M Carlin; J B Weller
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Cellular immunity to Bacteroides fragilis capsular polysaccharide.

Authors:  M E Shapiro; A B Onderdonk; D L Kasper; R W Finberg
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more
  12 in total

1.  Monocytic cell activation by Nonendotoxic glycoprotein from Prevotella intermedia ATCC 25611 is mediated by toll-like receptor 2.

Authors:  S Sugawara; S Yang; K Iki; J Hatakeyama; R Tamai; O Takeuchi; S Akashi; T Espevik; S Akira; H Takada
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration.

Authors:  Gabriela d'Empaire; Michael T Baer; Frank C Gibson
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

3.  Prophylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-3]-beta-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection.

Authors:  D S Kernodle; H Gates; A B Kaiser
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

4.  A novel component different from endotoxin extracted from Prevotella intermedia ATCC 25611 activates lymphoid cells from C3H/HeJ mice and gingival fibroblasts from humans.

Authors:  K Iki; K Kawahara; S Sawamura; R Arakaki; T Sakuta; A Sugiyama; H Tamura; T Sueda; S Hamada; H Takada
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci.

Authors:  Hiroshige Mikamo; Atul K Johri; Lawrence C Paoletti; Lawrence C Madoff; Andrew B Onderdonk
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction.

Authors:  Mohamed Hafez; Kelly Hayes; Marie Goldrick; Geoff Warhurst; Richard Grencis; Ian S Roberts
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

7.  Characterization of Bacteroides fragilis hemolysins and regulation and synergistic interactions of HlyA and HlyB.

Authors:  Kirstin P Robertson; C Jeffrey Smith; Andrea M Gough; Edson R Rocha
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

8.  The modulation of adaptive immune responses by bacterial zwitterionic polysaccharides.

Authors:  Tom Li Stephen; Laura Groneck; Wiltrud Maria Kalka-Moll
Journal:  Int J Microbiol       Date:  2010-12-22

9.  Mode of delivery and cord blood cytokines: a birth cohort study.

Authors:  Ngoc P Ly; Begoña Ruiz-Pérez; Andrew B Onderdonk; Arthur O Tzianabos; Augusto A Litonjua; Catherine Liang; Daniel Laskey; Mary L Delaney; Andrea M DuBois; Hara Levy; Diane R Gold; Louise M Ryan; Scott T Weiss; Juan C Celedón
Journal:  Clin Mol Allergy       Date:  2006-09-26

10.  The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts.

Authors:  Jorg Brunner; Nina Scheres; Nawal B El Idrissi; Dong M Deng; Marja L Laine; Arie J van Winkelhoff; Wim Crielaard
Journal:  BMC Microbiol       Date:  2010-01-11       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.